Express Pharma

What UPI did to consumers and businesses, UPHI will do to healthcare

Suresh Subramanian, Partner, National Life Sciences Leader at EY India speaks on making India Pharma Inc more 'value-driven' and shares his view on key focus areas such as expansion of PLI and RLI schemes, investments in R&D and innovation, power of emerging technologies, growth opportunities in newer areas like nutraceuticals etc, in an interaction with Viveka Roychowdhury

1 681